10-QPeriod: Q1 FY2005

IDEXX LABORATORIES INC /DE Quarterly Report for Q1 Ended Mar 31, 2005

Filed May 5, 2005For Securities:IDXX

Summary

IDEXX Laboratories, Inc. reported solid revenue growth for the first quarter of 2005, with total revenue increasing by 14.2% to $152.4 million compared to the same period in 2004. This growth was driven by a strong performance across all segments, particularly the Companion Animal Group (CAG) and Food Diagnostics Group (FDG), which saw increases of 13.7% and 25.6% respectively. The company's profitability remained robust, with gross profit rising by 13.5% and operating income showing a modest increase of 3.3%. While net income remained relatively flat year-over-year at $17.7 million, the company demonstrated effective cost management, with gross profit as a percentage of revenue remaining stable. Despite a slight increase in operating expenses as a percentage of revenue, driven by investments in growth initiatives and acquisitions, IDEXX's financial position appears stable. The company continues to execute its growth strategies, including new product development and integration of acquired businesses, positioning it for sustained performance.

Key Highlights

  • 1Total revenue increased 14.2% to $152.4 million for the three months ended March 31, 2005, compared to $133.4 million for the same period in 2004.
  • 2Companion Animal Group (CAG) revenue grew 13.7% to $124.9 million, driven by laboratory and consulting services, and instruments and consumables.
  • 3Food Diagnostics Group (FDG) revenue increased significantly by 25.6% to $14.7 million, largely due to higher livestock diagnostics sales.
  • 4Gross profit increased 13.5% to $76.1 million, with gross profit margin remaining stable at approximately 50%.
  • 5Operating income saw a modest increase of 3.3% to $26.1 million, indicating continued operational efficiency.
  • 6The company repurchased 530,800 shares of common stock for $29.5 million during the quarter, demonstrating a commitment to returning value to shareholders.
  • 7Cash flow from operations was $0.3 million, a decrease from $10.7 million in the prior year, attributed to seasonal increases in receivables and timing of payments.

Frequently Asked Questions

The primary driver of revenue growth was a broad-based increase across all segments, with notable strength in the Companion Animal Group (CAG) and Food Diagnostics Group (FDG). CAG's growth was fueled by laboratory and consulting services and instruments/consumables, while FDG saw significant expansion in livestock diagnostics.

Profitability remained strong, with gross profit increasing by 13.5% and the gross profit margin holding steady at around 50%. Operating income also increased by 3.3%. While net income was flat year-over-year, this reflects ongoing investments and strategic initiatives.

Cash flow from operations was lower in the first quarter of 2005 compared to the prior year, primarily due to seasonal increases in accounts receivable and the timing of payments. However, the company expects operating cash flow to improve over the remainder of the year.

Yes, the company repurchased 530,800 shares of its common stock for $29.5 million during the first quarter of 2005 as part of its ongoing share repurchase program.